TRANSFUSION-DEPENDENT Β-THALASSEMIA PATIENTS

Clinical trials for TRANSFUSION-DEPENDENT Β-THALASSEMIA PATIENTS explained in plain language.

Never miss a new study

Get alerted when new TRANSFUSION-DEPENDENT Β-THALASSEMIA PATIENTS trials appear

Sign up with your email to follow new studies for TRANSFUSION-DEPENDENT Β-THALASSEMIA PATIENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug duo aims to cut transfusions for blood disorder patients

Disease control Recruiting now

This study tests whether adding low-dose thalidomide to luspatercept can reduce the need for blood transfusions in adults with transfusion-dependent β-thalassemia. About 78 participants will receive either the combination or luspatercept alone. The main goal is to see if the comb…

Matched conditions: TRANSFUSION-DEPENDENT Β-THALASSEMIA PATIENTS

Phase: PHASE2 • Sponsor: Rongrong Liu • Aim: Disease control

Last updated May 16, 2026 22:42 UTC

TRANSFUSION-DEPENDENT Β-THALASSEMIA PATIENTS

Get alerted when new TRANSFUSION-DEPENDENT Β-THALASSEMIA PATIENTS trials appear

New drug duo aims to cut transfusions for blood disorder patients